Vincent Forlenza

Vincent Forlenza is an American business executive and corporate director known for his tenure as Chief Executive Officer and Chairman of Becton, Dickinson and Company and for subsequent roles on multiple corporate boards. He has been associated with major corporations, financial institutions, and nonprofit organizations across the United States and Europe, engaging with strategic operations, mergers and acquisitions, and governance matters. Forlenza's career intersects with leaders and institutions such as Roche, Johnson & Johnson, Medtronic, Eli Lilly and Company, and Pfizer within the global healthcare and medical device sectors.

Early life and education

Born in 1951, Forlenza completed undergraduate studies and advanced degrees at institutions that feed executives into multinational corporations. His formative years in higher education connected him to alumni networks at universities commonly associated with executive leadership, including Harvard University, Stanford University, Wharton School of the University of Pennsylvania, Columbia University, and MIT. During this period he encountered contemporaries who later worked at General Electric, IBM, Procter & Gamble, Boeing, and Ford Motor Company, shaping his orientation toward industrial management and international business.

Career

Forlenza's professional trajectory moved through roles in sales, marketing, operations, and general management across multinational firms tied to the medical device and pharmaceutical industries. Early career positions placed him in organizations with connections to GE Healthcare, Siemens Healthineers, Philips, Abbott Laboratories, and Baxter International. He ascended through executive ranks amid corporate strategic activity involving companies such as Takeda Pharmaceutical Company, GlaxoSmithKline, Novartis, Sanofi, and AstraZeneca. Throughout his career he engaged with capital markets and corporate finance actors including Goldman Sachs, Morgan Stanley, J.P. Morgan Chase, Bank of America, and Citigroup.

Leadership at Becton, Dickinson and Company

As Chief Executive Officer and later Chairman of Becton, Dickinson and Company, Forlenza led the firm through periods of product portfolio expansion, regulatory interaction, and international growth, positioning the company alongside peers like Cardinal Health, McKesson Corporation, Stryker Corporation, Zimmer Biomet, and Boston Scientific. Under his leadership, BD negotiated relationships and competed in markets shared with Roche Diagnostics, Siemens Healthineers, Abbott Diagnostics, Thermo Fisher Scientific, and PerkinElmer. Strategic decisions during his tenure involved mergers, acquisitions, and collaborations that placed BD in dialogue with corporations such as Kohlberg Kravis Roberts, The Carlyle Group, Bain Capital, Blackstone Group, and KKR & Co. Inc. and attracted attention from regulatory bodies like the U.S. Food and Drug Administration, European Medicines Agency, U.S. Securities and Exchange Commission, Federal Trade Commission, and national ministries of health in Germany and Japan.

Forlenza's operational oversight included manufacturing, supply chain, and quality programs interfacing with standards bodies and industry associations like the International Organization for Standardization, Association for the Advancement of Medical Instrumentation, AdvaMed, Medical Device Manufacturers Association, and World Health Organization. During his tenure BD expanded into emerging markets and forged ties with healthcare systems such as the National Health Service (England), the Centers for Medicare & Medicaid Services, and major hospital systems like Mayo Clinic, Cleveland Clinic, and Johns Hopkins Hospital.

Board memberships and affiliations

Following executive leadership, Forlenza served on the boards and advisory councils of several corporations and nonprofit entities, joining fellow directors from firms such as IBM, Intel Corporation, Microsoft, Apple Inc., and AT&T. His board service connected him with financial and industrial institutions including ExxonMobil, Chevron Corporation, Dow Chemical Company, DuPont, and 3M. He participated in governance activities with organizations like the American Red Cross, United Way, Rockefeller Foundation, Bill & Melinda Gates Foundation, and regional economic development councils associated with New Jersey and New York. Forlenza's affiliations extended to academic advisory roles linked to Harvard Business School, Wharton School, Columbia Business School, Kellogg School of Management, and INSEAD.

Personal life and philanthropy

Forlenza's personal and philanthropic engagements included support for cultural, educational, and health-related causes, collaborating with institutions such as Metropolitan Museum of Art, Lincoln Center, Carnegie Hall, Princeton University, Yale University, and Duke University. He participated in fundraising and governance activities with medical centers and public health initiatives connected to St. Jude Children's Research Hospital, Memorial Sloan Kettering Cancer Center, Dana–Farber Cancer Institute, American Cancer Society, and Doctors Without Borders. Forlenza's philanthropic profile also associated him with civic organizations and policy institutes such as the Brookings Institution, Council on Foreign Relations, Atlantic Council, Aspen Institute, and regional chambers of commerce.

Category:American chief executives